Filshtein AP

Pacific Institute of Bioorganic Chemistry. GB Elyakova Far Eastern Branch of the Russian Academy of Sciences

1
Publications
5
h-index
(72 citations, 15 total works)

Research Topics

Invertebrate Immune Response Mechanisms (7)Glycosylation and Glycoproteins Research (6)Aquaculture disease management and microbiota (4)Marine Sponges and Natural Products (3)Seaweed-derived Bioactive Compounds (3)

Alpha-gal Syndrome Publications

New l-Rhamnose-Binding Lectin from the Bivalve : Purification, Partial Structural Characterization and Antibacterial Activity.

Mizgina TO, Chikalovets IV, Bulanova TA, Molchanova VI, Filshtein AP, et al.
Marine drugs •

In this study, a new l-rhamnose-binding lectin (GYL-R) from the hemolymph of bivalve was purified using affinity and ion-exchange chromatography and functionally characterized. Lectin antimicrobial activity was examined in different ways. The lectin was inhibited by saccharides possessing the same configuration of hydroxyl groups at C-2 and C-4, such as l-rhamnose, d-galactose, lactose, l-arabinose and raffinose. Using the glycan microarray approach, natural carbohydrate ligands were established for GYL-R as l-Rha and glycans containing the α-Gal residue in the terminal position. The GYL-R molecular mass determined by MALDI-TOF mass spectrometry was 30,415 Da. The hemagglutination activity of the lectin was not affected by metal ions. The lectin was stable up to 75 °C and between pH 4.0 and 12.0. The amino acid sequence of the five GYL-R segments was obtained with nano-ESI MS/MS and contained both YGR and DPC-peptide motifs which are conserved in most of the l-rhamnose-binding lectin carbohydrate recognition domains. Circular dichroism confirmed that GYL is a α/β-protein with a predominance of the random coil. Furthermore, GYL-R was able to bind and suppress the growth of the Gram-negative bacteria by recognizing lipopolysaccharides. Together, these results suggest that GYL-R is a new member of the RBL family which participates in the self-defense mechanism against bacteria and pathogens with a distinct carbohydrate-binding specificity.